Barbara Sleight
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Lymphoblastic Leukemia research 15
- Oncology 10
- CAR-T cell therapy research 8
- HER2/EGFR in Cancer Research 2
- Co-authors
- Erik Vandendries (14 shared papers)Anjali S. Advani (13 shared papers)Hagop M. Kantarjian (13 shared papers)Matthias Stelljes (13 shared papers)Daniel J. DeAngelo (13 shared papers)Susan O’Brien (9 shared papers)Wendy Stock (11 shared papers)Michaela Liedtke (8 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (4 papers)Cancer (2 papers)Clinical Cancer Research (1 paper)Future Oncology (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Barbara Sleight
23 papers receiving 1.6k citations
Barbara Sleight's Hit Papers
Peers
Comparison fields: 5 of 67
- Hematology 585
- Public Health, Environmental and Occupational Health 909
- Oncology 836
- Pathology and Forensic Medicine 227
- Pediatrics, Perinatology and Child Health 195
Countries citing papers authored by Barbara Sleight
This map shows the geographic impact of Barbara Sleight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Sleight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Sleight more than expected).
Fields of papers citing papers by Barbara Sleight
This network shows the impact of papers produced by Barbara Sleight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Sleight. The network helps show where Barbara Sleight may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Sleight, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia Hit paper breakdown → | 2016 | 951 |
| 2 | Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study Hit paper breakdown → | 2019 | 242 |
| 3 | 2017 | 155 | |
| 4 | 2018 | 46 | |
| 5 | 2019 | 40 | |
| 6 | 2021 | 33 | |
| 7 | 1998 | 23 | |
| 8 | 2011 | 15 | |
| 9 | 2012 | 13 | |
| 10 | 2019 | 13 | |
| 11 | 2019 | 9 | |
| 12 | 1999 | 8 | |
| 13 | 2019 | 7 | |
| 14 | 2016 | 6 | |
| 15 | 2017 | 5 | |
| 16 | 2018 | 5 | |
| 17 | 2018 | 5 | |
| 18 | 2016 | 4 | |
| 19 | 2019 | 3 | |
| 20 | 2016 | 2 |
About Barbara Sleight
Barbara Sleight is a scholar working on Public Health, Environmental and Occupational Health, Oncology, Hematology, Genetics and Molecular Biology, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (15 papers), CAR-T cell therapy research (8 papers), Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Hedgehog Signaling Pathway Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Hematology (585 citations), Public Health, Environmental and Occupational Health (909 citations), Oncology (836 citations), Pathology and Forensic Medicine (227 citations) and Pediatrics, Perinatology and Child Health (195 citations). Barbara Sleight has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Erik Vandendries, Anjali S. Advani, Hagop M. Kantarjian, Matthias Stelljes, Daniel J. DeAngelo, Susan O’Brien, Wendy Stock, Michaela Liedtke, Nicola Gökbuget and Tao Wang. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Clinical Cancer Research and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.